Related references
Note: Only part of the references are listed.Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives
Jingjing Qu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Erb-B2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53-responsive microRNA-3184-5p in cervical cancer cells
Hongli Liu et al.
ONCOLOGY REPORTS (2021)
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
Giulia Agliardi et al.
NATURE COMMUNICATIONS (2021)
CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi et al.
STEM CELL RESEARCH & THERAPY (2021)
Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19
Loubna Mazini et al.
STEM CELL RESEARCH & THERAPY (2021)
Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2)
Homa Seyedmirzaei et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2021)
An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma
Rui Ma et al.
CANCER RESEARCH (2021)
Chimeric Antigen Receptor Design and Efficacy in Ovarian Cancer Treatment
Katarzyna M. Terlikowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma
Vanaja Konduri et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Switchable CAR-T Cells Outperformed Traditional AntibodyRedirected Therapeutics Targeting Breast Cancers
Yu J. Cao et al.
ACS SYNTHETIC BIOLOGY (2021)
Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition
Lin Xia et al.
CANCER IMMUNOLOGY RESEARCH (2021)
CAR-NK cell in cancer immunotherapy; A promising frontier
Faroogh Marofi et al.
CANCER SCIENCE (2021)
Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients
Yajun Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Cell death in pancreatic cancer: from pathogenesis to therapy
Xin Chen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Ehsan Razeghian et al.
STEM CELL RESEARCH & THERAPY (2021)
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
Faroogh Marofi et al.
FRONTIERS IN ONCOLOGY (2021)
Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity
Tyler Risom et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy
Chenggong Li et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2020)
PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumours
Florian Wiede et al.
EMBO JOURNAL (2020)
A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts
Gabor Toth et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CAR T cells: continuation in a revolution of immunotherapy
Anurag K Singh et al.
LANCET ONCOLOGY (2020)
Towards personalized treatment for early stage HER2-positive breast cancer
Kristina Goutsouliak et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
EGFRvIII-CAR-T Cells with PD-1 Knockout Have Improved Anti-Glioma Activity
Haifeng Zhu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study
Archana Thakur et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
Filippo Galli et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
Tsutomu Nakazawa et al.
CELLS (2020)
KHYG-1 Cells With EGFRvIII-specific CAR Induced a Pseudoprogression-like Feature in Subcutaneous Tumours Derived from Glioblastoma-like Cells
Tsutomu Nakazawa et al.
ANTICANCER RESEARCH (2020)
Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice
Tong Li et al.
BMC CANCER (2020)
Enhancement of the antitumor effect of HER2-directed CAR-T cells through blocking epithelial-mesenchymal transition in tumor cells
Peng-Fei Zhang et al.
FASEB JOURNAL (2020)
Targeting epidermal growth factor-overexpressing triple-negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
Yan Liu et al.
CELL PROLIFERATION (2020)
Combined antitumor effects of anti-EGFR variant III CAR-T cell therapy and PD-1 checkpoint blockade on glioblastoma in mouse model
Yujie Song et al.
CELLULAR IMMUNOLOGY (2020)
Next-Generation Manufacturing Protocols Enriching TSCMCAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
Silvia Arcangeli et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Third Generation Anti-HER2 Chimeric Antigen Receptor Mouse T Cells Alone or Together With Anti-PD1 Antibody Inhibits the Growth of Mouse Breast Tumor Cells Expressing HER2in vitroand in Immune Competent Mice
Panyuan Li et al.
FRONTIERS IN ONCOLOGY (2020)
A rational mouse model to detect on-target, off-tumor CAR T cell toxicity
Mauro Castellarin et al.
JCI INSIGHT (2020)
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
Meenakshi Hegde et al.
NATURE COMMUNICATIONS (2020)
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie et al.
EBIOMEDICINE (2020)
Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells
Yumi Fujimoto et al.
SCIENTIFIC REPORTS (2020)
Lenalidomide Enhances CAR-T Cell Activity Against Solid Tumor Cells
Zhixiong Wang et al.
CELL TRANSPLANTATION (2020)
EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo
Lin Xia et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
EGFRvIII-specific CAR-T cells produced by piggyBac transposon exhibit efficient growth suppression against hepatocellular carcinoma
Yuan Ma et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells
Claudia Arndt et al.
ONCOIMMUNOLOGY (2020)
TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors
Na Tang et al.
JCI INSIGHT (2020)
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
Deepak Raj et al.
GUT (2019)
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
Stephanie L. Goff et al.
JOURNAL OF IMMUNOTHERAPY (2019)
Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy
Zhao Zhang et al.
FRONTIERS OF MEDICINE (2019)
Engineering and Design of Chimeric Antigen Receptors
Sonia Guedan et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC
Qun Gao et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
Bryan D. Choi et al.
NATURE BIOTECHNOLOGY (2019)
HER2-specific chimeric antigen receptor-engineered natural killer cells combined with apatinib for the treatment of gastric cancer
Xian Wu et al.
BULLETIN DU CANCER (2019)
HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters
Marta Smolinska et al.
DISEASE MARKERS (2019)
Allogeneic CAR T cell therapies for leukemia
Waseem Qasim
AMERICAN JOURNAL OF HEMATOLOGY (2019)
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D. Choi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
Wanghong Hu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice
Elin M. V. Forsberg et al.
CANCER RESEARCH (2019)
EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC
Yan Liu et al.
AGING-US (2019)
Chimeric Antigen Receptor-modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model
Ruidi Teng et al.
JOURNAL OF IMMUNOTHERAPY (2019)
Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells
Dwivedi Alka et al.
FRONTIERS IN IMMUNOLOGY (2019)
Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
L. Herrera et al.
SCIENTIFIC REPORTS (2019)
HER2 regulates HIF-2 and drives an increased hypoxic response in breast cancer
Edward J. Jarman et al.
BREAST CANCER RESEARCH (2019)
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
Kevin Bielamowicz et al.
NEURO-ONCOLOGY (2018)
Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
Kaichao Feng et al.
PROTEIN & CELL (2018)
Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo
Yanjing Song et al.
PROTEIN & CELL (2018)
CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors
Claudia S. Marques et al.
BMC CANCER (2018)
HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3
Ana Ruiz-Saenz et al.
CANCER RESEARCH (2018)
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
Christopher C. Kloss et al.
MOLECULAR THERAPY (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice
He Li et al.
CELL DEATH & DISEASE (2018)
Overexpression of HER2 in the pancreas promotes development of intraductal papillary mucinous neoplasms in mice
Wataru Shibata et al.
SCIENTIFIC REPORTS (2018)
Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma Cells
Toshiharu Murakami et al.
ANTICANCER RESEARCH (2018)
Association of HER2 gene amplification and tumor progression in early gastric cancer
Kazuki Kanayama et al.
VIRCHOWS ARCHIV (2018)
CAR T Cells in Solid Tumors: Blueprints for Building effective Therapies
Hannah M. Knochelmann et al.
FRONTIERS IN IMMUNOLOGY (2018)
Universal CARs, universal T cells, and universal CAR T cells
Juanjuan Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
The functional verification of EGFR-CAR T-cells targeted to hypopharyngeal squamous cell carcinoma
Yi-Han Dong et al.
ONCOTARGETS AND THERAPY (2018)
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2 thorn Breast Cancer Metastasis to the Brain
Saul J. Priceman et al.
CLINICAL CANCER RESEARCH (2018)
CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
Xiaojuan Liu et al.
CELL RESEARCH (2017)
Donor origin CAR T cells: graft versus malignancy effect without GVHD, a systematic review
Faiz Anwer et al.
IMMUNOTHERAPY (2017)
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Mingxue Fan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer
Yoonjin Kwak et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma
Eiji Oki et al.
ONCOLOGY (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Driving better and safer HER2-specific CARs for cancer therapy
Xianqiang Liu et al.
ONCOTARGET (2017)
Serum SDF-1 levels are a reliable diagnostic marker of feline mammary carcinoma, discriminating HER2-overexpressing tumors from other subtypes
Claudia S. Marques et al.
ONCOTARGET (2017)
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp et al.
SCIENTIFIC REPORTS (2017)
Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting
Agnieszka Adamczyk et al.
JOURNAL OF CANCER (2017)
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
Qing Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Generation of Off-the-Shelf Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
Jieming Zeng et al.
STEM CELL REPORTS (2017)
Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
Anushruti Sarvaria et al.
FRONTIERS IN IMMUNOLOGY (2017)
CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells
Yongping Zhang et al.
FRONTIERS OF MEDICINE (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
HER2 signaling regulates HER2 localization and membrane retention
Jaekwang Jeong et al.
PLOS ONE (2017)
Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts
Jessica Hartmann et al.
EMBO MOLECULAR MEDICINE (2017)
Natural killer cell adoptive immunotherapy: Coming of age
Leticia Baggio et al.
CLINICAL IMMUNOLOGY (2017)
Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy
Heena Singla et al.
CURRENT CANCER DRUG TARGETS (2017)
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells
Sherly Mardiana et al.
CANCER RESEARCH (2017)
DNA methyltransferases and their roles in tumorigenesis
Wu Zhang et al.
BIOMARKER RESEARCH (2017)
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
Congcong Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
Congcong Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
Sabrina Genssler et al.
ONCOIMMUNOLOGY (2016)
Chimeric antigen receptors: driving immunology towards synthetic biology
Michel Sadelain
CURRENT OPINION IN IMMUNOLOGY (2016)
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape (Publication with Expression of Concern. See vol. 129, pg. 3464, 2019)
Meenakshi Hegde et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
HER2 Transmembrane Domain Dimerization Coupled with Self-Association of Membrane-Embedded Cytoplasmic Juxtamembrane Regions
Pavel E. Bragin et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials
Susan D. Richman et al.
JOURNAL OF PATHOLOGY (2016)
HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers
Bob T. Li et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer
Hawa Nalwoga et al.
PLOS ONE (2016)
A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
Xilin Chen et al.
ONCOTARGET (2016)
Combination Immunotherapy with NY-ESO-1-Specific CAR+ T Cells with T-Cell Vaccine Improves Anti-Myeloma Effect
Krina Patel et al.
BLOOD (2016)
HER2 expression status in diverse cancers: review of results from 37,992 patients
Min Yan et al.
CANCER AND METASTASIS REVIEWS (2015)
Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
Xiaojun Liu et al.
CANCER RESEARCH (2015)
New Cell Sources for T Cell Engineering and Adoptive Immunotherapy
Maria Themeli et al.
CELL STEM CELL (2015)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma
Laura A. Johnson et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Expression of COX-2 and HER-2 in colorectal cancer and their correlation
Qi-Bing Wu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
Matthew J. Frigault et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Advantages and applications of CAR-expressing natural killer cells
Wolfgang Glienke et al.
FRONTIERS IN PHARMACOLOGY (2015)
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
Jianfeng Han et al.
SCIENTIFIC REPORTS (2015)
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
Kurt Schönfeld et al.
MOLECULAR THERAPY (2014)
Efficacy of CAR T-cell Therapy in Large Tumors Relies upon Stromal Targeting by IFNγ
Ana Textor et al.
CANCER RESEARCH (2014)
HER2 Expression and PI3K-Akt Pathway Alterations in Gastric Cancer
Yasutaka Sukawa et al.
DIGESTION (2014)
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
Michael C. Jensen et al.
IMMUNOLOGICAL REVIEWS (2014)
EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer
Christiane Daniela Fichter et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
Katarzyna Urbanska et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer
R. Nair et al.
ONCOGENE (2014)
Tyrosine phosphatase PTPα contributes to HER2-evoked breast tumor initiation and maintenance
D. S. Meyer et al.
ONCOGENE (2014)
Frozen Cord Blood Hematopoietic Stem Cells Differentiate into Higher Numbers of Functional Natural Killer Cells In Vitro than Mobilized Hematopoietic Stem Cells or Freshly Isolated Cord Blood Hematopoietic Stem Cells
Martha Luevano et al.
PLOS ONE (2014)
The Role of High Mobility Group Box 1 in Innate Immunity
Shin-Ae Lee et al.
YONSEI MEDICAL JOURNAL (2014)
Construction and evaluation of a novel humanized HER2-specific chimeric receptor
Meili Sun et al.
BREAST CANCER RESEARCH (2014)
Epidermal Growth Factor Receptor (EGFR) Signaling Promotes Proliferation and Survival in Osteoprogenitors by Increasing Early Growth Response 2 (EGR2) Expression
Abhishek Chandra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
Meenakshi Hegde et al.
MOLECULAR THERAPY (2013)
Latest research and treatment of advanced-stage epithelial ovarian cancer
Robert L. Coleman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation
Martha Luevano et al.
HUMAN IMMUNOLOGY (2012)
Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels
Evripidis Lanitis et al.
PLOS ONE (2012)
Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer
Stephanie J. Gros et al.
PLOS ONE (2012)
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
Jan Spanholtz et al.
PLOS ONE (2011)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments
Fabricio F. T. Barros et al.
HISTOPATHOLOGY (2010)
Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells
Angel Ayuso-Sacido et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
HER2 overexpression correlates with survival after curative resection of pancreatic cancer
Masahiro Komoto et al.
CANCER SCIENCE (2009)
Resistance to Trastuzumab in Breast Cancer
Paula R. Pohlmann et al.
CLINICAL CANCER RESEARCH (2009)
The promise and potential pitfalls of chimeric antigen receptors
Michel Sadelain et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
EGFR signaling regulates the proliferation of Drosophila adult midgut progenitors
Huaqi Jiang et al.
DEVELOPMENT (2009)
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer
F. R. Hirsch et al.
ONCOGENE (2009)
Transcriptional Activation of hTERT in Breast Carcinomas by the Her2-ER81-Related Pathway
Dimitra Vageli et al.
ONCOLOGY RESEARCH (2009)
Cross-Talk Between the ErbB/HER Family and the Type I Insulin-Like Growth Factor Receptor Signaling Pathway in Breast Cancer
Quanri Jin et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2008)
The HER family and cancer: emerging molecular mechanisms and therapeutic targets
Natalia V. Sergina et al.
TRENDS IN MOLECULAR MEDICINE (2007)
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
M. M. Moasser
ONCOGENE (2007)
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains
Jinjuan Wang et al.
HUMAN GENE THERAPY (2007)
Regression of experimental medulloblastoma following transfer of HER2-specific T cells
Nabil Ahmed et al.
CANCER RESEARCH (2007)
A dimerization hierarchy in the transmembrane domains of the HER receptor family
Jean-Pierre Duneau et al.
BIOCHEMISTRY (2007)
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway
D. Pils et al.
BRITISH JOURNAL OF CANCER (2007)
Role of HER receptors family in development and differentiation
P Casalini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
HER2 and COX2 expression in human prostate cancer
J Edwards et al.
EUROPEAN JOURNAL OF CANCER (2004)
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
YM Li et al.
CANCER CELL (2004)
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors
AW Burgess et al.
MOLECULAR CELL (2003)
Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood
H Tanaka et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction
C Uherek et al.
BLOOD (2002)
Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer - Evidence for involvement of AP-1 and PEA3
K Subbaramaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1
DG Bosc et al.
ONCOGENE (2001)
Share Paper
